SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001023024-23-000017
Filing Date
2023-08-09
Accepted
2023-08-09 07:00:53
Documents
83
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q anip-20230630.htm   iXBRL 10-Q 1699587
2 EX-31.1 anip-20230630x10qxexx311.htm EX-31.1 10312
3 EX-31.2 anip-20230630x10qxexx312.htm EX-31.2 9841
4 EX-32.1 anip-20230630x10qxexx321.htm EX-32.1 7024
  Complete submission text file 0001023024-23-000017.txt   8904749

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anip-20230630.xsd EX-101.SCH 51442
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anip-20230630_cal.xml EX-101.CAL 79963
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anip-20230630_def.xml EX-101.DEF 348205
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anip-20230630_lab.xml EX-101.LAB 798788
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anip-20230630_pre.xml EX-101.PRE 551148
77 EXTRACTED XBRL INSTANCE DOCUMENT anip-20230630_htm.xml XML 1298501
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 231153303
SIC: 2834 Pharmaceutical Preparations